The 17 references in paper A. Yarovoy A., O. Golubeva V., S. Kleyankina S., V. Yarovaya A., А. Яровой А., О. Голубева В., С. Клеянкина С., В. Яровая А. (2016) “Результаты хирургического и лучевого лечения меланомы конъюнктивы // Results of surgical and radiation treatment of conjunctival melanoma” / spz:neicon:ogsh:y:2016:i:3:p:38-41

1
Бровкина А.Ф., Вальский В.Г., Гусев Г.А. и др. Офтальмоонкология: руководство для врачей. М.: Медицина, 2002. [Brovkina A.F., Valsky V.G., Gusev G.A. et al. Ophthalmic oncology: a guideline for physicians. M.: Medicine, 2002. (In Russ.)].
(check this in PDF content)
2
Бровкина А.Ф., Гришина Е.Е., Яценко О.Ю., Андрейченко А.М. Первый опыт лечения Ингароном меланомы конъюнктивы. Опухоли головы и шеи 2012;(2): 9–12. [Brovkina A.F., Grishina E.E., Yatsenko O.Yu., Andreichenko A.M. First experience of treatment of conjunctival melanoma with Ingaron. Opukholi golovy i shei = Head and neck tumors 2012(2): 9–12. (In Russ.)].
(check this in PDF content)
3
Вальский В.В., Зарубей Г.Д. Крупнофракционная брахитерапия злокачественных опухолей конъюнктивы. Достижения и перспективы офтальмоонкологии: Сб. трудов МНИИ глазных болезней им. Гельм- гольца. 2001. С. 98–100. [Valsky V.V., Zarubey G.D. Large-fraction brachytherapy of malignant tumors of conjunctiva. Achievements and Prospects of Ophthalmic Oncology: collection of scientific papers of Moscow Research Institute of Eye Diseases named after Helmholtz. 2001. Pp. 98–100. (In Russ.)].
(check this in PDF content)
4
Chang A.E., Karnell L.H., Menck H.R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83(8): 1664–78. Fernandes B.F., Nikolitch K., Coates J. et al. Local chemotherapeutic agents for the treatment of ocular malignancies. Surv Ophthalmol 2014;59(1): 97–114.
(check this in PDF content)
5
Finger P.T., Sedeek R.W., Chin K.J. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 2008;145(1):124–9.
(check this in PDF content)
6
Isager P., Engholm G., Overgaard J., Storm H. Uveal and conjunctival malignant melanoma in Denmark 1943–97: observed and relative survival of patients followed through 2002. Ophthalmic Epidemiol 2006;13(2):85–96.
(check this in PDF content)
7
James R. Wong, Afshan A. Nanji, Anat Galor, Carol L. Karp. Management of conjunctival malignant melanoma: a review and update. Expert Rev Ophthalmol 2014;9(3):185–204.
(check this in PDF content)
8
Karim R., Conway R.M. Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma. Clin Experiment 2011;39(4):293–8.
(check this in PDF content)
9
Krause L., Mladenova A., Bechrakis N.E. et al. Treatment modalities for conjunctival melanoma. Klin Monatsblätter für Augenheilkd 2009;226(12):1012–6.
(check this in PDF content)
10
Kurli M., Finger P.T. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol 2005;243(11):1108–14.
(check this in PDF content)
11
Lommatzsch P.K., Lommatzsch R.E., Kirsch I., Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990;74(10):615–9.
(check this in PDF content)
12
Missotten G., De Keizer R., Spileers W. et al. Strontium brachytherapy in conjunctival melanoma. Acta Ophthalmol 2011;89:248.
(check this in PDF content)
13
Shields J.A., Shields C.L., De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol 1997;115(6):808–15.
(check this in PDF content)
14
Shields C.L., Kaliki S., Al-Dahmash S.A. et al. American Joint Committee on Cancer (AJCC) Clinical Classification Predicts Conjunctival Melanoma Outcomes. Ophthal Plast Reconstr Surg 2012;28(5):313–23.
(check this in PDF content)
15
Shields C.L., Shields J.A., Gündüz K. et al. Conjunctival Melanoma: Risk Factors for Recurrence, Exenteration, Metastasis, and Death in 150 Consecutive Patients. Arch Ophthalmol 2000;118(11):1497.
(check this in PDF content)
16
Tuomaala S., Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: Implications for sentinel lymph node biopsy. Ophthalmology 2004; 111(4):816–21.
(check this in PDF content)
17
Wuestemeyer H., Sauerwein W., Meller D. et al. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 2005;244(4):438–46.
(check this in PDF content)